{"id":55645,"date":"2023-04-10T16:03:38","date_gmt":"2023-04-10T14:03:38","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/medgenome-to-exhibit-proprietary-sequencing-and-informatics-solutions-at-the-american-association-for-cancer-research-annual-meeting\/"},"modified":"2023-04-10T16:03:38","modified_gmt":"2023-04-10T14:03:38","slug":"medgenome-to-exhibit-proprietary-sequencing-and-informatics-solutions-at-the-american-association-for-cancer-research-annual-meeting","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/medgenome-to-exhibit-proprietary-sequencing-and-informatics-solutions-at-the-american-association-for-cancer-research-annual-meeting\/","title":{"rendered":"MedGenome to Exhibit Proprietary Sequencing and Informatics Solutions at the American Association for Cancer Research Annual Meeting"},"content":{"rendered":"
\n

FOSTER CITY, Calif.–(BUSINESS WIRE)–#AACR<\/a>—MedGenome<\/a>, a global precision medicine company specializing in omics solutions, today announced that it will be exhibiting at the American Association for Cancer Research Annual Meeting on April 14 \u2013 19, 2023 in Orlando, Florida.<\/p>\n

<\/a><\/p>\n

\nMedGenome will be at Booth #2074 to exhibit its advanced single cell sequencing and immune repertoire profiling solutions<\/a>. MedGenome’s advanced analyses pipeline provides researchers with a comprehensive report which includes publication ready tables, plots and detailed metrics to visualize and interpret the results. MedGenome will also exhibit its end-to-end sequencing and informatics solutions to analyze T-cell receptor (TCR) and B-cell receptor (BCR) repertoires for antibody and diagnostics marker discovery projects.<\/p>\n

\nHiranjith GH, Site Head and VP of Research Services at MedGenome and his team will be at Booth #2074. For more information, or to schedule a meeting with the MedGenome team at the American Association for Cancer Research Annual Meeting, reach out to the contact below.<\/b><\/p>\n

\nAbout MedGenome<\/b><\/p>\n

\nMedGenome<\/a> is a genomics-driven research and diagnostics company with a mission to improve global health by decoding the genetic information contained in an individual\u2019s genome. MedGenome\u2019s powerful genomics solutions accelerate biomarker identification and discovery research for pharma and biotech companies. Their unique access to genomics data with clinical and phenotypic data provides insights into complex diseases at the genetic and molecular level to facilitate research in personalized healthcare. MedGenome is backed by a global investor base spanning Europe, Asia, and Africa, including support from Novo Holdings, one of the world\u2019s leading life sciences investors. MedGenome\u2019s high-throughput next-generation sequencing lab is in Foster City, California. Follow us on Twitter<\/b><\/a> and LinkedIn<\/b><\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nHiranjith GH, Site Head and VP of Research Services, MedGenome
\n
hiranjith.gh@medgenome.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

FOSTER CITY, Calif.–(BUSINESS WIRE)–#AACR—MedGenome, a global precision medicine company specializing in omics solutions, today announced that it will be exhibiting at the American Association for Cancer Research Annual Meeting on April 14 \u2013 19, 2023 in Orlando, Florida. MedGenome will be at Booth #2074 to exhibit its advanced single cell sequencing and immune repertoire profiling … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55645","6":"format-standard","7":"category-industry"},"yoast_head":"\nMedGenome to Exhibit Proprietary Sequencing and Informatics Solutions at the American Association for Cancer Research Annual Meeting - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/medgenome-to-exhibit-proprietary-sequencing-and-informatics-solutions-at-the-american-association-for-cancer-research-annual-meeting\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MedGenome to Exhibit Proprietary Sequencing and Informatics Solutions at the American Association for Cancer Research Annual Meeting - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"FOSTER CITY, Calif.–(BUSINESS WIRE)–#AACR—MedGenome, a global precision medicine company specializing in omics solutions, today announced that it will be exhibiting at the American Association for Cancer Research Annual Meeting on April 14 \u2013 19, 2023 in Orlando, Florida. MedGenome will be at Booth #2074 to exhibit its advanced single cell sequencing and immune repertoire profiling ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/medgenome-to-exhibit-proprietary-sequencing-and-informatics-solutions-at-the-american-association-for-cancer-research-annual-meeting\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-04-10T14:03:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230410005069\/en\/1758956\/21\/MedGenome_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medgenome-to-exhibit-proprietary-sequencing-and-informatics-solutions-at-the-american-association-for-cancer-research-annual-meeting\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medgenome-to-exhibit-proprietary-sequencing-and-informatics-solutions-at-the-american-association-for-cancer-research-annual-meeting\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"MedGenome to Exhibit Proprietary Sequencing and Informatics Solutions at the American Association for Cancer Research Annual Meeting\",\"datePublished\":\"2023-04-10T14:03:38+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medgenome-to-exhibit-proprietary-sequencing-and-informatics-solutions-at-the-american-association-for-cancer-research-annual-meeting\\\/\"},\"wordCount\":301,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medgenome-to-exhibit-proprietary-sequencing-and-informatics-solutions-at-the-american-association-for-cancer-research-annual-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230410005069\\\/en\\\/1758956\\\/21\\\/MedGenome_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medgenome-to-exhibit-proprietary-sequencing-and-informatics-solutions-at-the-american-association-for-cancer-research-annual-meeting\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medgenome-to-exhibit-proprietary-sequencing-and-informatics-solutions-at-the-american-association-for-cancer-research-annual-meeting\\\/\",\"name\":\"MedGenome to Exhibit Proprietary Sequencing and Informatics Solutions at the American Association for Cancer Research Annual Meeting - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medgenome-to-exhibit-proprietary-sequencing-and-informatics-solutions-at-the-american-association-for-cancer-research-annual-meeting\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medgenome-to-exhibit-proprietary-sequencing-and-informatics-solutions-at-the-american-association-for-cancer-research-annual-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230410005069\\\/en\\\/1758956\\\/21\\\/MedGenome_Logo.jpg\",\"datePublished\":\"2023-04-10T14:03:38+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medgenome-to-exhibit-proprietary-sequencing-and-informatics-solutions-at-the-american-association-for-cancer-research-annual-meeting\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medgenome-to-exhibit-proprietary-sequencing-and-informatics-solutions-at-the-american-association-for-cancer-research-annual-meeting\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medgenome-to-exhibit-proprietary-sequencing-and-informatics-solutions-at-the-american-association-for-cancer-research-annual-meeting\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230410005069\\\/en\\\/1758956\\\/21\\\/MedGenome_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230410005069\\\/en\\\/1758956\\\/21\\\/MedGenome_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/medgenome-to-exhibit-proprietary-sequencing-and-informatics-solutions-at-the-american-association-for-cancer-research-annual-meeting\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MedGenome to Exhibit Proprietary Sequencing and Informatics Solutions at the American Association for Cancer Research Annual Meeting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MedGenome to Exhibit Proprietary Sequencing and Informatics Solutions at the American Association for Cancer Research Annual Meeting - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/medgenome-to-exhibit-proprietary-sequencing-and-informatics-solutions-at-the-american-association-for-cancer-research-annual-meeting\/","og_locale":"en_US","og_type":"article","og_title":"MedGenome to Exhibit Proprietary Sequencing and Informatics Solutions at the American Association for Cancer Research Annual Meeting - Pharma Trend","og_description":"FOSTER CITY, Calif.–(BUSINESS WIRE)–#AACR—MedGenome, a global precision medicine company specializing in omics solutions, today announced that it will be exhibiting at the American Association for Cancer Research Annual Meeting on April 14 \u2013 19, 2023 in Orlando, Florida. MedGenome will be at Booth #2074 to exhibit its advanced single cell sequencing and immune repertoire profiling ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/medgenome-to-exhibit-proprietary-sequencing-and-informatics-solutions-at-the-american-association-for-cancer-research-annual-meeting\/","og_site_name":"Pharma Trend","article_published_time":"2023-04-10T14:03:38+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230410005069\/en\/1758956\/21\/MedGenome_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/medgenome-to-exhibit-proprietary-sequencing-and-informatics-solutions-at-the-american-association-for-cancer-research-annual-meeting\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/medgenome-to-exhibit-proprietary-sequencing-and-informatics-solutions-at-the-american-association-for-cancer-research-annual-meeting\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"MedGenome to Exhibit Proprietary Sequencing and Informatics Solutions at the American Association for Cancer Research Annual Meeting","datePublished":"2023-04-10T14:03:38+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/medgenome-to-exhibit-proprietary-sequencing-and-informatics-solutions-at-the-american-association-for-cancer-research-annual-meeting\/"},"wordCount":301,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/medgenome-to-exhibit-proprietary-sequencing-and-informatics-solutions-at-the-american-association-for-cancer-research-annual-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230410005069\/en\/1758956\/21\/MedGenome_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/medgenome-to-exhibit-proprietary-sequencing-and-informatics-solutions-at-the-american-association-for-cancer-research-annual-meeting\/","url":"https:\/\/pharma-trend.com\/en\/medgenome-to-exhibit-proprietary-sequencing-and-informatics-solutions-at-the-american-association-for-cancer-research-annual-meeting\/","name":"MedGenome to Exhibit Proprietary Sequencing and Informatics Solutions at the American Association for Cancer Research Annual Meeting - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/medgenome-to-exhibit-proprietary-sequencing-and-informatics-solutions-at-the-american-association-for-cancer-research-annual-meeting\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/medgenome-to-exhibit-proprietary-sequencing-and-informatics-solutions-at-the-american-association-for-cancer-research-annual-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230410005069\/en\/1758956\/21\/MedGenome_Logo.jpg","datePublished":"2023-04-10T14:03:38+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/medgenome-to-exhibit-proprietary-sequencing-and-informatics-solutions-at-the-american-association-for-cancer-research-annual-meeting\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/medgenome-to-exhibit-proprietary-sequencing-and-informatics-solutions-at-the-american-association-for-cancer-research-annual-meeting\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/medgenome-to-exhibit-proprietary-sequencing-and-informatics-solutions-at-the-american-association-for-cancer-research-annual-meeting\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230410005069\/en\/1758956\/21\/MedGenome_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230410005069\/en\/1758956\/21\/MedGenome_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/medgenome-to-exhibit-proprietary-sequencing-and-informatics-solutions-at-the-american-association-for-cancer-research-annual-meeting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"MedGenome to Exhibit Proprietary Sequencing and Informatics Solutions at the American Association for Cancer Research Annual Meeting"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55645","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55645"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55645\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55645"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55645"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55645"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}